Gerald Wirnsberger

Vienna, Austria

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications

Jagunal homolog 1 safeguards neutrophil immune function by preserving protein sialylation during differentiation.

Jagunal homolog 1 safeguards neutrophil immune function by preserving protein sialylation during differentiation.

Journal: Blood advances
Published: January 20, 2026

Inhalation of ACE2 as a therapeutic target on sex-bias differences in SARS-CoV-2 infection and variant of concern.

Inhalation of ACE2 as a therapeutic target on sex-bias differences in SARS-CoV-2 infection and variant of concern.

Journal: iScience
Published: April 11, 2023

Author Correction: Force-tuned avidity of spike variant-ACE2 interactions viewed on the single-molecule level.

Author Correction: Force-tuned avidity of spike variant-ACE2 interactions viewed on the single-molecule level.

Journal: Nature communications
Published: February 28, 2023

Force-tuned avidity of spike variant-ACE2 interactions viewed on the single-molecule level.

Force-tuned avidity of spike variant-ACE2 interactions viewed on the single-molecule level.

Journal: Nature communications
Published: June 17, 2022

Development of an aerosol intervention for COVID-19 disease: Tolerability of soluble ACE2 (APN01) administered via nebulizer.

Development of an aerosol intervention for COVID-19 disease: Tolerability of soluble ACE2 (APN01) administered via nebulizer.

Journal: PloS one
Published: February 10, 2022

FIBCD1 is an endocytic GAG receptor associated with a novel neurodevelopmental disorder.

FIBCD1 is an endocytic GAG receptor associated with a novel neurodevelopmental disorder.

Journal: EMBO molecular medicine
Published: February 04, 2022

ACE2 is the critical in vivo receptor for SARS-CoV-2 in a novel COVID-19 mouse model with TNF- and IFNγ-driven immunopathology.

ACE2 is the critical in vivo receptor for SARS-CoV-2 in a novel COVID-19 mouse model with TNF- and IFNγ-driven immunopathology.

Journal: eLife
Published: October 11, 2021

Clinical grade ACE2 as a universal agent to block SARS-CoV-2 variants.

Clinical grade ACE2 as a universal agent to block SARS-CoV-2 variants.

Journal: EMBO molecular medicine
Published: September 30, 2021

Development of a novel, pan-variant aerosol intervention for COVID-19.

Development of a novel, pan-variant aerosol intervention for COVID-19.

Journal: bioRxiv : the preprint server for biology
Published: September 21, 2021

Clinical grade ACE2 as a universal agent to block SARS-CoV-2 variants.

Clinical grade ACE2 as a universal agent to block SARS-CoV-2 variants.

Journal: bioRxiv : the preprint server for biology
Published: September 21, 2021

Structure-guided glyco-engineering of ACE2 for improved potency as soluble SARS-CoV-2 decoy receptor.

Structure-guided glyco-engineering of ACE2 for improved potency as soluble SARS-CoV-2 decoy receptor.

Journal: eLife
Published: September 06, 2021

Identification of lectin receptors for conserved SARS-CoV-2 glycosylation sites.

Identification of lectin receptors for conserved SARS-CoV-2 glycosylation sites.

Journal: The EMBO journal
Published: March 31, 2021
Showing 1-12 of 26

Last Updated: 09/26/2026